Dr. John Brownstein, co-founder of Circulation, was faced with getting vaccines to patients. What he discovered was how a company like Uber could be the answer. This video was produced by the MM&M Content Lab in partnership with Klick Health. Make the journey


Five things for pharma marketers to know: Friday, May 26, 2017

Five things for pharma marketers to know: Friday, May 26, 2017

FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes

Following Tymlos approval, Radius uses Facebook to educate about osteoporosis

Following Tymlos approval, Radius uses Facebook to educate about osteoporosis

The company said adult women between the ages of 50 and 70 are most likely to share content on the social media platform.

The FDA cites risk info in letter over Contrave DTC ad

The FDA cites risk info in letter over Contrave DTC ad

The regulator also took issue with how Orexigen Therapeutics presented the risk information

Nearly every $100,000 drug approved in the last three years was for a rare disease

Nearly every $100,000 drug approved in the last three years was for a rare disease

This includes Sarepta Therapeutics' Exondys 5 and Vertex Pharmaceuticals' Orkambi.

Five things for pharma marketers to know: Thursday, May 25, 2017

Five things for pharma marketers to know: Thursday, May 25, 2017

Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug

Twitter launches DM cards for brands

Twitter launches DM cards for brands

Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.

Five things for pharma marketers to know: Wednesday, May 24, 2017

Five things for pharma marketers to know: Wednesday, May 24, 2017

Keytruda receives first approval based on a genetic feature and not tumor's location; Alexion reps reportedly crossed ethical lines; profits up at insurers

Alexion hires new chief commercial officer

Alexion hires new chief commercial officer

Brian Goff is expected to replace Carsten Thiel in June. The drugmaker said Tuesday that Thiel along with several other execs would be leaving the firm.

Otsuka, Proteus refile their sensor-enabled drug

Otsuka, Proteus refile their sensor-enabled drug

The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.

The class of 2017 wants it all: Work-life balance and a well-paid future

The class of 2017 wants it all: Work-life balance and a well-paid future

Recent grads aren't afraid to voice their expectations, and agencies are responding with new programs and policies.

The FDA says Puma's breast-cancer drug is effective, cautions about side effects

The FDA says Puma's breast-cancer drug is effective, cautions about side effects

An FDA advisory committee is expected to decide Wednesday whether to recommend neratinib for approval.

Five things for pharma marketers to know: Tuesday, May 23, 2017

Five things for pharma marketers to know: Tuesday, May 23, 2017

Disease awareness ads can boost drug sales; AstraZeneca's experimental asthma drug cuts steroid use; FDA approves Regeneron and Sanofi's RA drug

Five things for pharma marketers to know: Monday, May 22, 2017

Five things for pharma marketers to know: Monday, May 22, 2017

Amgen's osteoporosis drug set back by safety issue; new FDA digital biz to hire 13 engineers; Celgene's MS drug bests Avonex in trial

Apple helps a blind drummer and nonverbal teen thrive in new spots

Apple helps a blind drummer and nonverbal teen thrive in new spots

Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.

Expert Q&A: Getting patient centricity right

Expert Q&A: Getting patient centricity right

Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.

Five things for pharma marketers to know: Friday, May 19, 2017

Five things for pharma marketers to know: Friday, May 19, 2017

Keytruda gets two new FDA approvals; lawmakers aim to speed up approval of generics; Incyte uses soap opera to spread rare-disease awareness

Read the complete May 2017 digital edition

Read the complete May 2017 digital edition

Here you'll find everything from our May 2017 issue, including our Top 40 Transformers, deep dive into autoimmune drugs, and more.

Study: One-third of docs trust pharma content on HCP sites

Study: One-third of docs trust pharma content on HCP sites

In general, physicians believe that information provided by pharma companies is difficult to find and lacking in science.

Five things for pharma marketers to know: Thursday, May 18, 2017

Five things for pharma marketers to know: Thursday, May 18, 2017

Docs spend little time telling patients about cancer costs; Shire to file hereditary angioedema drug with the FDA by 2018; Philips CEO on access obstacles

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.